Effects of bisphosphonates on osteoclastogenesis in RAW264.7 cells

  • Authors:
    • Keigo Abe
    • Yoshitaka Yoshimura
    • Yoshiaki Deyama
    • Takashi Kikuiri
    • Tomokazu Hasegawa
    • Kanchu Tei
    • Hisashi Shinoda
    • Kuniaki Suzuki
    • Yoshimasa Kitagawa
  • View Affiliations

  • Published online on: March 23, 2012     https://doi.org/10.3892/ijmm.2012.952
  • Pages: 1007-1015
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Bisphosphonates are used as therapeutic agents for the management of osteoporosis and other bone diseases. However, the precise effects and mechanisms of bisphosphonates on osteoclastogenesis are unclear, as previous studies have reported contradictory findings and no studies have circumstantially assessed the effects of bisphosphonates on osteoclastogenesis. Therefore, the aim of this study was to determine the effects of bisphosphonates on osteoclastogenesis in RAW264.7 (RAW) cells. To examine the direct effects of bisphosphonates on osteoclast differentiation via receptor activator of nuclear factor-κB (RANK) ligand (RANKL), RAW cells were cultured with bisphosphonates. Addition of bisphosphonates to RAW cells led to a significant decrease in the number of osteoclasts and large osteoclasts (≥8 nuclei) in a bisphosphonate concentration-dependent and time-dependent manner. The cytotoxicity of non-nitrogen-containing bisphosphonates was specific to osteoclasts, while nitrogen-containing bisphosphonates were cytotoxic and induced cell death in both osteoclasts and RAW cells. Resorption activity was significantly diminished by treatment with bisphosphonates, thus confirming that bisphosphonates impair the absorptive activity of osteoclasts. We also investigated the effects of bisphosphonates on the mRNA expression of genes associated with osteoclastogenesis, osteoclast-specific markers and apoptosis-related genes using quantitative real-time PCR. The results suggest that bisphosphonates suppress osteoclast differentiation and infusion, and induce osteoclast apoptosis. With regard to osteoclast apoptosis induced by bisphosphonates, we further investigated the detection of DNA fragmentation and Caspase-Glo 3/7 assay. DNA fragmentation was confirmed after treatment with bisphosphonates, while caspase-3/7 activity increased significantly when compared with controls. In conclusion, bisphosphonates directly inhibited RANKL-stimulated osteoclast differentiation and fusion in RAW cells. It was confirmed that bisphosphonates impair osteoclast resorption activity and induce apoptosis. The effects of non-nitrogen-containing bisphosphonates were also specific to osteoclasts, while nitrogen-containing bisphosphonates were cytotoxic and induced cell death in both osteoclasts and RAW cells.

Related Articles

Journal Cover

June 2012
Volume 29 Issue 6

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Abe K, Yoshimura Y, Deyama Y, Kikuiri T, Hasegawa T, Tei K, Shinoda H, Suzuki K and Kitagawa Y: Effects of bisphosphonates on osteoclastogenesis in RAW264.7 cells . Int J Mol Med 29: 1007-1015, 2012
APA
Abe, K., Yoshimura, Y., Deyama, Y., Kikuiri , T., Hasegawa, T., Tei, K. ... Kitagawa, Y. (2012). Effects of bisphosphonates on osteoclastogenesis in RAW264.7 cells . International Journal of Molecular Medicine, 29, 1007-1015. https://doi.org/10.3892/ijmm.2012.952
MLA
Abe, K., Yoshimura, Y., Deyama, Y., Kikuiri , T., Hasegawa, T., Tei, K., Shinoda, H., Suzuki, K., Kitagawa, Y."Effects of bisphosphonates on osteoclastogenesis in RAW264.7 cells ". International Journal of Molecular Medicine 29.6 (2012): 1007-1015.
Chicago
Abe, K., Yoshimura, Y., Deyama, Y., Kikuiri , T., Hasegawa, T., Tei, K., Shinoda, H., Suzuki, K., Kitagawa, Y."Effects of bisphosphonates on osteoclastogenesis in RAW264.7 cells ". International Journal of Molecular Medicine 29, no. 6 (2012): 1007-1015. https://doi.org/10.3892/ijmm.2012.952